Search research articles
Contact Us
Filters
Showing results (531-540 of 626) with videos related to
Page
of 63
Sort By:
The Journal of Allergy and Clinical Immunology
|
October 25, 2011
Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence
L Keoki Williams, Edward L Peterson, Karen Wells, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 27, 2007
High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma
Adrian J C Bloor, Kirsty Thomson, Noha Chowdhry, et al.
Clinical Therapeutics
|
March 22, 2021
Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial
Azmi Nasser, Tesfaye Liranso, Toyin Adewole, et al.
Journal of the American College of Cardiology
|
November 23, 2006
Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype
Srijita Sen-Chowdhry, Sanjay K Prasad, Petros Syrris, et al.
Brain and Behavior
|
November 16, 2016
A machine learning approach to identify functional biomarkers in human prefrontal cortex for individuals with traumatic brain injury using functional near-infrared spectroscopy
Nader Karamzadeh, Franck Amyot, Kimbra Kenney, et al.
Clinical Therapeutics
|
July 30, 2020
A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children
Azmi Nasser, Tesfaye Liranso, Toyin Adewole, et al.
Free Radical Biology & Medicine
|
November 17, 2009
Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis
Sudhir Chowdhry, Maiiada H Nazmy, Paul J Meakin, et al.
Oncogene
|
July 11, 2017
Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses
L Torrente, C Sanchez, R Moreno, et al.
Journal of Clinical Psychopharmacology
|
June 28, 2021
A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder
Azmi Nasser, Tesfaye Liranso, Toyin Adewole, et al.
Mucosal Immunology
|
February 4, 2016
KLF6 contributes to myeloid cell plasticity in the pathogenesis of intestinal inflammation
W A Goodman, S Omenetti, D Date, et al.
Page
of 63
Search research articles
Search
Showing results (531-540 of 626) with videos related to
Sort By:
Page
of 63
The Journal of Allergy and Clinical Immunology
|
October 25, 2011
Quantifying the proportion of severe asthma exacerbations attributable to inhaled corticosteroid nonadherence
L Keoki Williams, Edward L Peterson, Karen Wells, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 27, 2007
High response rate to donor lymphocyte infusion after allogeneic stem cell transplantation for indolent non-Hodgkin lymphoma
Adrian J C Bloor, Kirsty Thomson, Noha Chowdhry, et al.
Clinical Therapeutics
|
March 22, 2021
Once-Daily SPN-812 200 and 400 mg in the treatment of ADHD in School-aged Children: A Phase III Randomized, Controlled Trial
Azmi Nasser, Tesfaye Liranso, Toyin Adewole, et al.
Journal of the American College of Cardiology
|
November 23, 2006
Cardiovascular magnetic resonance in arrhythmogenic right ventricular cardiomyopathy revisited: comparison with task force criteria and genotype
Srijita Sen-Chowdhry, Sanjay K Prasad, Petros Syrris, et al.
Brain and Behavior
|
November 16, 2016
A machine learning approach to identify functional biomarkers in human prefrontal cortex for individuals with traumatic brain injury using functional near-infrared spectroscopy
Nader Karamzadeh, Franck Amyot, Kimbra Kenney, et al.
Clinical Therapeutics
|
July 30, 2020
A Phase III, Randomized, Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children
Azmi Nasser, Tesfaye Liranso, Toyin Adewole, et al.
Free Radical Biology & Medicine
|
November 17, 2009
Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis
Sudhir Chowdhry, Maiiada H Nazmy, Paul J Meakin, et al.
Oncogene
|
July 11, 2017
Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses
L Torrente, C Sanchez, R Moreno, et al.
Journal of Clinical Psychopharmacology
|
June 28, 2021
A Phase 3, Placebo-Controlled Trial of Once-Daily Viloxazine Extended-Release Capsules in Adolescents With Attention-Deficit/Hyperactivity Disorder
Azmi Nasser, Tesfaye Liranso, Toyin Adewole, et al.
Mucosal Immunology
|
February 4, 2016
KLF6 contributes to myeloid cell plasticity in the pathogenesis of intestinal inflammation
W A Goodman, S Omenetti, D Date, et al.
Page
of 63